Publication | Closed Access

Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice

Antifibrotic TherapyCyclophosphamide-induced Lung FibrosisInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationMedicinePathologyPulmonary PharmacologyPulmonary FibrosisPharmacologyPulmonary Disease